This article first appeared on GuruFocus.

CryoPort Inc (NASDAQ:CYRX) is set to release its Q3 2025 earnings on Nov 4, 2025. The consensus estimate for Q3 2025 revenue is $41.36 million, and the earnings are expected to come in at -$0.21 per share. The full year 2025's revenue is expected to be $171.03 million and the earnings are expected to be $0.18 per share. More detailed estimate data can be found on the Forecast page.

Warning! GuruFocus has detected 6 Warning Signs with CYRX.

Is CYRX fairly valued? Test your thesis with our free DCF calculator.

Revenue estimates for CryoPort Inc (NASDAQ:CYRX) have increased from $169.25 million to $171.04 million for the full year 2025 and from $185.08 million to $186.78 million for 2026 over the past 90 days. Earnings estimates have risen from -$0.95 per share to $0.18 per share for the full year 2025 and from -$0.75 per share to -$0.71 per share for 2026 over the past 90 days.

In the previous quarter ending on June 30, 2025, CryoPort Inc's (NASDAQ:CYRX) actual revenue was $45.45 million, which beat analysts' revenue expectations of $41.73 million by 8.93%. CryoPort Inc's (NASDAQ:CYRX) actual earnings were $2.05 per share, which exceeded analysts' expectations of -$0.24 per share by 950.62%. Following the release of these results, CryoPort Inc (NASDAQ:CYRX) was down by 5.87% in one day.

Based on the one-year price targets offered by 9 analysts, the average target price for CryoPort Inc (NASDAQ:CYRX) is $12.67, with a high estimate of $16 and a low estimate of $8. The average target implies an upside of 37.01% from the current price of $9.25.

According to GuruFocus estimates, the estimated GF Value for CryoPort Inc (NASDAQ:CYRX) in one year is $10.43, suggesting an upside of 12.82% from the current price of $9.25.

Based on the consensus recommendation from 9 brokerage firms, CryoPort Inc's (NASDAQ:CYRX) average brokerage recommendation is currently 1.7, indicating an \\"Outperform\\" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.